系统发育分析提示印度南部H58沙门菌流行时间更长
研究对印度南部1991—2016年26年间分离的194株伤寒沙门菌临床株进行全基因组测序与SNP分析,并开展抗菌药物敏感性检测。结果显示多重耐药相关4.3.1基因型为优势克隆,最早可追溯至1991年,多数对氟喹诺酮类耐药但非多重耐药。
要点
- 印度南部4.3.1基因型伤寒沙门菌已流行约二十年。
- 1991年即检出4.3.1株,为印度最早报告。
- 当地4.3.1株多为氟喹诺酮耐药而非多重耐药。
核心结论
- 4.3.1基因型伤寒沙门菌在Vellore地区已流行约二十年,研究有助于公共卫生机构追踪该克隆在印度及全球的传播与持续存在。
- 研究提示临床医生当地流行克隆的耐药模式,可为预防和治疗决策提供参考。
研究设计与样本
- 对印度南部1991—2016年26年间血液和骨髓培养分离的194株伤寒沙门菌临床株进行分析。
- 对多数常见临床抗菌药物进行药敏检测,并开展全基因组测序与SNP水平分析及比较基因组学分析。
主要发现
- 多重耐药相关clade 4.3.1为优势基因型。
- 4.3.1型伤寒沙门菌最早于1991年检出,为印度最早报告,其中多数对氟喹诺酮耐药且非多重耐药。
- Vellore其他流行基因型中未检出多重耐药。
- 与全球伤寒沙门菌比较,Vellore分离株分为两个亚组(I和II),与南亚(亚组I、II)及东南亚(亚组II)分支高度相关。
关键数值与推荐
- 研究纳入194株临床伤寒沙门菌,时间跨度为1991—2016年共26年。
- 4.3.1型最早检出年份为1991年。
临床怎么用
- 临床可参考当地流行克隆的耐药模式,为伤寒的经验性治疗和预防决策提供依据。
- 公共卫生机构可借助系统发育监测追踪4.3.1克隆的传播与持续存在。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Typhoid fever caused by Salmonella Typhi is a major public health concern in low-/middle-income countries. A recent study of 1900 global S. Typhi indicated that South Asia might be the site of the original emergence of the most successful and hypervirulent clone belonging to the 4.3.1 genotype. However, this study had limited samples from India. METHODS: We analyzed 194 clinical S. Typhi, temporal representatives from those isolated from blood and bone marrow cultures in southern India, over 26 years (1991-2016). Antimicrobial resistance (AMR) testing was performed for most common clinical agents. Whole-genome sequencing and SNP-level analysis was conducted. Comparative genomics of Vellore isolates was performed to infer transmission and AMR events. RESULTS: We identified multidrug-resistance (MDR)-associated clade 4.3.1 as the dominant genotype. We detected 4.3.1 S. Typhi as early as 1991, the earliest to be reported form India, and the majority were fluoroquinolone resistant and not MDR. MDR was not detected at all in other genotypes circulating in Vellore. Comparison with global S. Typhi showed 2 Vellore subgroups (I and II) that were phylogenetically highly related to previously described South Asia (subgroup I, II) and Southeast Asia (subgroup II) clades. CONCLUSIONS: 4.3.1 S. Typhi has dominated in Vellore for 2 decades. Our study would assist public health agencies in better tracking of transmission and persistence of this successful clade in India and globally. It informs clinicians of the AMR pattern of circulating clone, which would add confidence to their prophylactic/treatment decision making and facilitate efficient patient care.
引用
- Pragasam AK, Pickard D, Wong V, et al. Phylogenetic Analysis Indicates a Longer Term Presence of the Globally Distributed H58 Haplotype of Salmonella Typhi in Southern India. Clin Infect Dis. 2020. PMID: 32003431. doi:10.1093/cid/ciz1112
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。